Literature DB >> 15676129

[Evaluation of a home hospitalization program in patients with exacerbations of chronic obstructive pulmonary disease].

S Díaz Lobato1, F González Lorenzo, M A Gómez Mendieta, S Mayoralas Alises, I Martín Arechabala, C Villasante Fernández-Montes.   

Abstract

OBJECTIVE: We carried out a randomized controlled trial to evaluate the efficacy of a home hospitalization (HH) program for patients hospitalized for exacerbation of chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS: Patients who were clinically stable and had stable arterial blood gases were randomized to the conventional hospitalization group or the HH group.
RESULTS: Of the 88 patients evaluated, 40 (20 in each group) were enrolled. No differences were observed in baseline characteristics, in clinical recovery, or arterial blood gases between the 2 groups at discharge. At 1-month follow up there were no differences in mortality or in the number of readmissions. The mean length of hospitalization in patients with HH was 9.2 days (4 days in hospital and 5 days at home), compared to 12.2 days in patients with conventional hospitalization.
CONCLUSIONS: Our results show that a hospital-supervised HH program including the participation of pneumologists and nursing staff allows for the recovery of patients hospitalized for exacerbation of COPD who have stable symptoms and arterial blood gases with no increase in the rate of readmission, relapse, or therapeutic failure.

Entities:  

Mesh:

Year:  2005        PMID: 15676129     DOI: 10.1016/s1579-2129(06)60387-x

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  7 in total

1.  [Home hospitalisation in patients with COPD].

Authors:  María Teresa García Sanz; Francisco Javier González Barcala; Luís Valdés Cuadrado
Journal:  Aten Primaria       Date:  2009-05-21       Impact factor: 1.137

Review 2.  Home care by outreach nursing for chronic obstructive pulmonary disease.

Authors:  Christopher X Wong; Kristin V Carson; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

3.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

Review 4.  Early discharge hospital at home.

Authors:  Daniela C Gonçalves-Bradley; Steve Iliffe; Helen A Doll; Joanna Broad; John Gladman; Peter Langhorne; Suzanne H Richards; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2017-06-26

5.  Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Maureen P M H Rutten-van Mölken; Monique van Vliet; Maria W Braken; Loes M G A van Eijsden; Onno C P van Schayck
Journal:  BMJ Open       Date:  2012-10-16       Impact factor: 2.692

6.  Patients with acute exacerbation of chronic obstructive pulmonary disease feel safe when treated at home: a qualitative study.

Authors:  Ying Wang; Torbjørn Haugen; Sissel Steihaug; Anne Werner
Journal:  BMC Pulm Med       Date:  2012-08-24       Impact factor: 3.317

7.  [Integral approach to the acute exacerbation of chronic obstructive pulmonary disease].

Authors:  J González Del Castillo; F J Candel; J de la Fuente; F Gordo; F J Martín-Sánchez; R Menéndez; A Mujal; J Barberán
Journal:  Rev Esp Quimioter       Date:  2018-10-04       Impact factor: 1.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.